Company
Boundless Bio, Inc. (BOLD)
Standardized SEC financial data for Boundless Bio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001782303 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-59.0%
Free cash flow
-$47.2M
Current ratio
8.74×
EPS (diluted)
$-2.60
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $42.6M | $55.3M | $44.8M |
| SG&A expense | $12.2M | $18.0M | $18.7M |
| Operating income | -$54.8M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $11.5M | $24.3M | $152.1M | $107.6M |
| Total current assets | — | $124.2M | $154.4M | $109.6M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$46.9M | -$60.8M | -$46.7M |
| Capital expenditures | $633K | $2.5M | $546K |
| Free cash flow | -$47.5M | -$63.4M |
Get BOLD data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BOLD/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BOLD/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"